Collectively, these results suggest that GLK overexpression in T cells induces IL-17A production and pathogenic Th17 cells, contributing to the pathogenesis of a distinct subpopulation of patients with SLE. This evidence concerns the gene MAP4K3 and systemic lupus erythematosus.